BAKS MEDICAL Trademark

Trademark Overview


On Wednesday, April 24, 2024, a trademark application was filed for BAKS MEDICAL with the United States Patent and Trademark Office. The USPTO has given the BAKS MEDICAL trademark a serial number of 98516483. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Thursday, November 14, 2024. This trademark is owned by BAKS Medical, Inc.. The BAKS MEDICAL trademark is filed in the Medical Instrument Products category with the following description:

Medical device for auto-transfusion of blood; Blood transfusion apparatus; Medical device for treating post-partum hemorrhage

General Information


Serial Number98516483
Word MarkBAKS MEDICAL
Filing DateWednesday, April 24, 2024
Status641 - NON-FINAL ACTION - MAILED
Status DateThursday, November 14, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesMedical device for auto-transfusion of blood; Blood transfusion apparatus; Medical device for treating post-partum hemorrhage

Classification Information


International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateWednesday, April 24, 2024
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameBAKS Medical, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressOakbrook Terrace, IL 60181

Trademark Events


Event DateEvent Description
Wednesday, April 24, 2024NEW APPLICATION ENTERED
Sunday, October 13, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, November 7, 2024ASSIGNED TO EXAMINER
Thursday, November 14, 2024NON-FINAL ACTION WRITTEN
Thursday, November 14, 2024NON-FINAL ACTION E-MAILED
Thursday, November 14, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED